Barclays lowered the firm’s price target on Adient to $24 from $29 and keeps an Equal Weight rating on the shares. The Q3 miss was dragged by EMEA margin weakness and “mutes” the surprise Americas beat, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADNT:
- Adient cuts FY24 revenue view to $14.6B from $14.8B-$14.9B, consensus $14.84B
- Adient reports Q3 adjusted EPS 32c, consensus 64c
- Adient reports Q3 financial results; provides update to FY24 outlook
- ADNT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Adient price target lowered to $40 from $42 at BofA